The Global Biopharmaceutical Contract Manufacturing Organization (CMO) Market was valued at USD 15.3 billion in 2023 and is expected to reach USD 58.2 billion by 2032, growing at a compound annual growth rate (CAGR) of 16.0% during the forecast period from 2024 to 2032. The market's expansion is driven by the increasing demand for outsourced manufacturing services, the growing Biopharmaceutical ..
